Empowered Patient Podcast
Immunotherapies Using Fully Human Polyclonal Antibodies Without Need for Convalescent Plasma Blood Donors with Eddie Sullivan SAb Biotherapeutics
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:26
- Mas informaciones
Informações:
Sinopsis
Eddie Sullivan, President, CEO, Co-Founder, SAb Biotherapeutics talks about their innovative technology to generate targeted highly potent immunotherapies on a large scale. SAb is producing fully human polyclonal antibodies targeted to COVID-19 without the need for convalescent plasma blood donations by using genetically engineered cattle which produce the fully human antibodies. @SABBantibody #COVID19 #immunotherapies #antibodies SAbbiotherapeutics.com/covid-19 Download the transcript here
